Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Esthesioneuroblastoma.

Heidi D Klepin1, Kevin P McMullen, Glenn J Lesser

  • 1Section of Hematology and Oncology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA. hklepin@wfubmc.edu

Current Treatment Options in Oncology
|October 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Declines in Social Support During Breast Cancer Treatment and Their Association With Exercise Capacity Reductions in Breast Cancer Survivors.

American journal of lifestyle medicine·2026
Same author

Effect of Donepezil on Dimensions of Patient-Reported Cognitive Impairment in Breast Cancer Survivors: Secondary Analysis of the NCORP REMEMBER Trial (WF-97116).

JCO oncology advances·2026
Same author

Examining recruitment differences by race, ethnicity, and age to a decentralized trial of an internet-delivered intervention for sexual health after breast cancer: the WF-2202 SHINE trial.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Elevated Plasma IL-18 Levels During Chemotherapy Treatment for Breast Cancer, Exercise Capacity, and Physical Activity.

JACC. CardioOncology·2026
Same author

Sarcopenia in Older Adults with Hematologic Malignancies: A Comprehensive Review of Epidemiology, Prognosis, and Interventions.

Cancers·2026
Same author

Muscle quality during cancer treatment and associations with health-related quality of life.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026
Same journal

Interaction between Regulated Cell Death Pathways and Core Cellular Processes: Unraveling the Molecular Mechanisms of Cardiotoxicity of Antitumor Drugs.

Current treatment options in oncology·2026
Same journal

Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

Current treatment options in oncology·2026
Same journal

Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review.

Current treatment options in oncology·2026
Same journal

The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue Sarcomas.

Current treatment options in oncology·2026
Same journal

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.

Current treatment options in oncology·2026
Same journal

Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research.

Current treatment options in oncology·2026
See all related articles

Esthesioneuroblastoma treatment lacks consensus, but combined surgery and radiation offer the best survival outcomes. Chemotherapy is beneficial alongside surgery and radiation, especially for advanced or recurrent esthesioneuroblastoma.

Area of Science:

  • Oncology
  • Head and Neck Surgery

Background:

  • Esthesioneuroblastoma is a rare malignant tumor originating in the olfactory epithelium.
  • Current treatment strategies for esthesioneuroblastoma lack a universally accepted evidence-based consensus.

Purpose of the Study:

  • To review and synthesize the current literature on esthesioneuroblastoma treatment.
  • To identify optimal therapeutic approaches for improved patient outcomes.

Main Methods:

  • Literature review of published studies on esthesioneuroblastoma management.
  • Analysis of treatment modalities including surgery, radiation, and chemotherapy.
  • Evaluation of disease-free and overall survival based on treatment combinations.

Main Results:

Related Experiment Videos

  • Multimodality therapy combining surgery and radiation demonstrates superior disease-free and overall survival rates.
  • Craniofacial surgical approaches are preferred for resection when feasible.
  • Chemotherapy is not recommended as a sole initial treatment but shows benefit when combined with surgery and radiation, particularly for advanced or metastatic disease.

    • Conclusions:

    • A combined modality approach of surgery and radiation is the cornerstone of effective esthesioneuroblastoma treatment.
    • Chemotherapy plays a crucial role as an adjuvant or salvage therapy in advanced, unresectable, or recurrent esthesioneuroblastoma.
    • Further research is needed to establish definitive evidence-based guidelines for esthesioneuroblastoma management.